25.58  0.19 (0.75%)		12-22 16:00
Open: 25.39 High: 26.06 Volume: 112,100		Pre. Close: 25.39 Low: 25.39 Market Cap: 307(M)

Short term
Mid term
Targets	6-month :	36.17	1-year :	40.63
Resists	First :	30.97	Second :	34.79
Pivot price	28.2
Supports	First :	24.79	Second :	20.63
MAs	MA(5) :	25.39	MA(20) :	29.1
	MA(100) :	33.12	MA(250) :	0
MACD	MACD :	-2.1	Signal :	-1.7
%K %D	K(14,3) :	4.9	D(3) :	3.9
RSI	RSI(14): 35.5
52-week	High :	39.91	Low :	18.35

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ XOMA ] has closed above bottom band by 28.4%. Bollinger Bands are 120% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	26.08 - 26.18	26.18 - 26.3
Low:	25.12 - 25.23	25.23 - 25.35
Close:	25.38 - 25.55	25.55 - 25.75

XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Mon, 22 Dec 2025
XOMA Royalty Corporation Announces Cash Dividends for Preferred Stockholders - Quiver Quantitative

Mon, 22 Dec 2025
XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewswire

Mon, 22 Dec 2025
Two XOMA preferred share classes pay cash to holders in January - Stock Titan

Sun, 21 Dec 2025
XOMA Royalty (NASDAQ:XOMA) shareholders have earned a 13% CAGR over the last three years - Yahoo Finance

Wed, 17 Dec 2025
Generation Bio announces merger with XOMA Royalty - MSN

Tue, 16 Dec 2025
Generation Bio is latest Mass. biotech to be acquired by Xoma - The Business Journals

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	12 (M)
Shares Float	10 (M)
Held by Insiders	1.7 (%)
Held by Institutions	67.6 (%)
Shares Short	366 (K)
Shares Short P.Month	268 (K)

EPS	0.75
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	7.13
Profit Margin	45.9 %
Operating Margin	-14.3 %
Return on Assets (ttm)	1.4 %
Return on Equity (ttm)	22.4 %
Qtrly Rev. Growth	29.8 %
Gross Profit (p.s.)	3.61
Sales Per Share	3.8
EBITDA (p.s.)	0.63
Qtrly Earnings Growth	0 %
Operating Cash Flow	5 (M)
Levered Free Cash Flow	-63 (M)

PE Ratio	34.1
PEG Ratio	0
Price to Book value	3.58
Price to Sales	6.72
Price to Cash Flow	57.89

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.